Kevin McCulloch serves as the President and Chief Operating Officer at XERIS BIOPHARMA HOLDINGS INC, a specialty pharmaceutical company dedicated to developing and commercializing innovative therapies for patient populations with significant unmet medical needs. McCulloch has been instrumental in steering the company's strategic direction and operational execution, leveraging his extensive experience in the biopharmaceutical industry. Prior to joining XERIS BIOPHARMA HOLDINGS INC, McCulloch held several senior leadership positions at various biopharmaceutical companies. He has a proven track record of driving growth and operational excellence, having successfully led product development, commercialization, and business development initiatives. His strategic vision and leadership have been key to advancing XERIS BIOPHARMA HOLDINGS INC's mission to deliver life-changing therapies to patients. In his role as President and COO, McCulloch oversees the company's day-to-day operations, ensuring that XERIS BIOPHARMA HOLDINGS INC remains at the forefront of innovation in the biopharmaceutical sector. His contributions have been vital in expanding the company's product portfolio and strengthening its market position. Under his leadership, XERIS BIOPHARMA HOLDINGS INC continues to make significant strides in improving patient outcomes and advancing the field of medicine.